🇳🇱 Netherlands Country × Condition
prostate cancer Clinical Trials in Netherlands
Active clinical trials for prostate cancer with research sites in Netherlands. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 Phases: Phase 1, Phase 2, Phase 3 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇳🇱 Netherlands
Active Trials in Netherlands (4)
NCT05000827
Recruiting
Dutch National Randomized Study: PSMA-PET/CT As a Triage Tool for Pelvic Lymph Node Dissection in Prostatectomy Patients
Enrollment
706 pts
Country
🇳🇱 Netherlands
Canisius-Wilhelmina Hospital
View Trial → NCT05413850 Phase 1, Phase 2
Recruiting
Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
Enrollment
82 pts
Country
🇳🇱 Netherlands
Blue Earth Therapeutics Ltd
View Trial → NCT06122584 Phase 3
Recruiting
Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed Prostate Cancer
Enrollment
434 pts
Country
🇳🇱 Netherlands
ABX advanced biochemical compounds ...
View Trial → NCT04075305
Recruiting
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Enrollment
8,000 pts
Country
🇳🇱 Netherlands
UMC Utrecht
View Trial → Frequently Asked Questions
How many prostate cancer clinical trials are active in Netherlands?
There are currently 4 active clinical trials for prostate cancer with sites in Netherlands, of which 4 are actively recruiting patients.
How can I join a prostate cancer clinical trial in Netherlands?
To join a prostate cancer clinical trial in Netherlands, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Netherlands directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are prostate cancer trials in Netherlands?
Active prostate cancer trials in Netherlands span Phase 1, Phase 2, Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology